Items where Author is "Lundberg, P."
Number of items: 5. 2016Theocharides, A. P. and Lundberg, P. and Lakkaraju, A. K. and Lysenko, V. and Myburgh, R. and Aguzzi, A. and Skoda, R. C. and Manz, M. G.. (2016) Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. Blood, 127 (25). pp. 3253-3259. 2015Karow, A. and Nienhold, R. and Lundberg, P. and Peroni, E. and Putti, M. C. and Randi, M. L. and Skoda, Radek C.. (2015) Mutational profile of childhood myeloproliferative neoplasms. Leukemia, 29 (12). pp. 2407-2409. 2013Grisouard, J. and Ojeda-Uribe, M. and Looser, R. and Hao-Shen, H. and Lundberg, P. and Duek, A. and Jeandidier, E. and Karow, A. and Skoda, R. C.. (2013) Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia. Blood, Vol. 122, H. 22. pp. 3694-3696. Kubovcakova, L. and Lundberg, P. and Grisouard, J. and Hao-Shen, H. and Romanet, V. and Andraos, R. and Murakami, M. and Dirnhofer, S. and Wagner, K. U. and Radimerski, T. and Skoda, R. C.. (2013) Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model. Blood, Vol. 121, H. 7. pp. 1188-1199. Girsberger, S. and Karow, A. and Lundberg, P. and Dirnhofer, S. and Lehmann, T. and Passweg, J. R. and Tichelli, A. and Skoda, R. and Rovo, A.. (2013) JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia : a case report. Acta Haematologica, 129 (1). pp. 23-25. |
